Barnoy S, Glaser T, Kosower N S
Department of Human Genetics, Sackler School of Medicine, Tel Aviv University, Israel.
Biochim Biophys Acta. 1998 Mar 12;1402(1):52-60. doi: 10.1016/s0167-4889(97)00144-4.
Calpain (Ca(2+)-activated cysteine protease) induced proteolysis has been suggested to play a role in myoblast fusion. We previously found that calpastatin (the endogenous inhibitor of calpain) diminishes markedly in myoblasts during myoblast differentiation just prior to the start of fusion, allowing Ca(2+)-induced calpain activation at that stage. Here, we show that a limited degradation of some proteins occurs within the myoblasts undergoing fusion, but not in proliferating myoblasts. The protein degradation is observed at the stage when calpastatin is low. Protein degradation within the myoblasts and myoblast fusion are inhibited by EGTA, by the cysteine protease inhibitors calpeptin and E-64d and by calpastatin. The degradation appears to be selective for certain myoblast proteins. Integrin beta 1 subunit, talin and beta-tropomyosin are degraded in the fusing myoblasts, whereas alpha-actinin, beta-tubulin and alpha-tropomyosin are not. A similar pattern of degradation is observed in lysates of proliferating myoblasts when Ca2+ and excess calpain are added, a degradation that is inhibited by calpastatin. The results support the notion that degradation of certain proteins is required for myoblast fusion and that calpain participates in the fusion-associated protein degradation. Participation of calpain is made possible by a change in calpain/calpastatin ratio, i.e., by a diminution in calpastatin level from a high level in the proliferating myoblasts to a low level in the differentiating myoblasts. Degradation of certain proteins, known to be responsible for the stability of the membrane-skeleton organization and for the interaction of the cell with the extracellular matrix, would allow destabilization of the membrane and the creation of membrane fusion-potent regions.
钙蛋白酶(Ca(2+)激活的半胱氨酸蛋白酶)诱导的蛋白水解作用被认为在成肌细胞融合过程中发挥作用。我们之前发现,在成肌细胞分化过程中,就在融合开始之前,钙蛋白酶抑制蛋白(钙蛋白酶的内源性抑制剂)在成肌细胞中显著减少,从而使得在该阶段Ca(2+)诱导钙蛋白酶激活。在此,我们表明,在正在融合的成肌细胞内会发生某些蛋白质的有限降解,但在增殖的成肌细胞中则不会。这种蛋白质降解在钙蛋白酶抑制蛋白水平较低的阶段被观察到。成肌细胞内的蛋白质降解以及成肌细胞融合受到乙二醇双四乙酸(EGTA)、半胱氨酸蛋白酶抑制剂钙肽素和E-64d以及钙蛋白酶抑制蛋白的抑制。这种降解似乎对某些成肌细胞蛋白质具有选择性。整合素β1亚基、踝蛋白和β-原肌球蛋白在正在融合的成肌细胞中被降解,而α-辅肌动蛋白、β-微管蛋白和α-原肌球蛋白则未被降解。当添加Ca2+和过量钙蛋白酶时,在增殖成肌细胞的裂解物中观察到类似的降解模式,这种降解受到钙蛋白酶抑制蛋白的抑制。这些结果支持了这样一种观点,即某些蛋白质的降解是成肌细胞融合所必需的,并且钙蛋白酶参与了与融合相关的蛋白质降解。钙蛋白酶的参与是通过钙蛋白酶/钙蛋白酶抑制蛋白比例的变化实现的,也就是说,通过钙蛋白酶抑制蛋白水平从增殖成肌细胞中的高水平降低到分化成肌细胞中的低水平。已知某些负责膜骨架组织稳定性以及细胞与细胞外基质相互作用的蛋白质的降解,将使膜不稳定并产生膜融合潜能区域。